Stay updated on N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial

Sign up to get notified when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has removed significant content related to a clinical study on N-Acetyl Cysteine for treating therapy-resistant major depressive disorder, including details about the study's purpose, methodology, and contact information.
    Difference
    84%
    Check dated 2025-05-07T19:37:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:21:00.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and the addition of a new version revision. The focus appears to have shifted towards a more concise presentation of the study's purpose and location.
    Difference
    32%
    Check dated 2025-04-16T09:55:13.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T04:57:15.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:18:11.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:29:59.000Z thumbnail image

Stay in the know with updates to N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.